(New York, NY) – July 1, 2014 – AiCure, an artificial intelligence company providing advanced facial recognition solutions to monitor medication adherence, today announced that Adam Hanina, Chief Executive Officer, will present at the 4th Annual Conference on Disruptive Innovations to Advance Clinical Trials on September 11-12, 2014. Hanina has been invited to participate in the 3rd Annual DPharm Idol: Quick Fire Disruptive Technology Presentations in an “American Idol” Format to show how their technology is advancing clinical development.
-
Share
-
Recent Press
-
Jul 29, 2026
AICure Expands Executive Leadership to Accelerate AI-Powered Medication Adherence, Remote Weight Verification, and Enterprise White-Label Solutions
-
Jul 21, 2026
Forbes: The AI Company Transforming Medication Adherence And Weight Loss
-
May 29, 2025
AiCure Appoints Sabina Chadha as CEO, Ed Ikeguchi Transitions to Chief Medical Officer, and Josh Wilson Promoted to COO and President
-
Jul 29, 2026